199 related articles for article (PubMed ID: 21920159)
1. Nevirapine plasma concentrations in premature infants exposed to single-dose nevirapine for prevention of mother-to-child transmission of HIV-1.
Mugabo P; Els I; Smith J; Rabie H; Smith P; Mirochnick M; Steyn W; Hall D; Madsen R; Cotton MF
S Afr Med J; 2011 Sep; 101(9):655-8. PubMed ID: 21920159
[TBL] [Abstract][Full Text] [Related]
2. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
; de Vincenzi I
Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
[TBL] [Abstract][Full Text] [Related]
3. Association of cord blood nevirapine concentration with reported timing of dose and HIV-1 transmission.
Jackson JB; Parsons T; Musoke P; Nakabiito C; Donnell D; Fleming T; Mirochnick M; Mofenson L; Fowler MG; Mmiro F; Guay L
AIDS; 2006 Jan; 20(2):217-22. PubMed ID: 16511414
[TBL] [Abstract][Full Text] [Related]
4. Development of nevirapine resistance in infants is reduced by use of infant-only single-dose nevirapine plus zidovudine postexposure prophylaxis for the prevention of mother-to-child transmission of HIV-1.
Eshleman SH; Hoover DR; Hudelson SE; Chen S; Fiscus SA; Piwowar-Manning E; Jackson JB; Kumwenda NI; Taha TE
J Infect Dis; 2006 Feb; 193(4):479-81. PubMed ID: 16425125
[TBL] [Abstract][Full Text] [Related]
5. Nevirapine prophylaxis to prevent HIV-1 mother-to-child transmission: pharmacokinetic considerations in preterm infants.
Capretti MG; Marsico C; Conti M; Corvaglia LT; Arcuri S; Faldella G; Re MC
New Microbiol; 2016 Oct; 39(4):314-316. PubMed ID: 27284987
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV.
Chalermchockcharoenkit A; Culnane M; Chotpitayasunondh T; Vanprapa N; Leelawiwat W; Mock PA; Asavapiriyanont S; Teeraratkul A; McConnell MS; McNicholl JM; Tappero JW
Clin Infect Dis; 2009 Jul; 49(2):299-305. PubMed ID: 19522656
[TBL] [Abstract][Full Text] [Related]
7. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.
Moodley D; Moodley J; Coovadia H; Gray G; McIntyre J; Hofmyer J; Nikodem C; Hall D; Gigliotti M; Robinson P; Boshoff L; Sullivan JL;
J Infect Dis; 2003 Mar; 187(5):725-35. PubMed ID: 12599045
[TBL] [Abstract][Full Text] [Related]
8. Timing of maternal and neonatal dosing of nevirapine and the risk of mother-to-child transmission of HIV-1: HIVNET 024.
Chi BH; Wang L; Read JS; Sheriff M; Fiscus S; Brown ER; Taha TE; Valentine M; Goldenberg R
AIDS; 2005 Nov; 19(16):1857-64. PubMed ID: 16227794
[TBL] [Abstract][Full Text] [Related]
9. Mother-to-child transmission of HIV among women who chose not to exclusively breastfeed their infants in Pune, India.
Gupta A; Gupte N; Sastry J; Bharucha KE; Bhosale R; Kulkarni P; Tripathy S; Nayak U; Phadke M; Bollinger RC;
Indian J Med Res; 2007 Aug; 126(2):131-4. PubMed ID: 17932438
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, placebo-controlled trial of combined nevirapine and zidovudine compared with nevirapine alone in the prevention of perinatal transmission of HIV in Zimbabwe.
Thistle P; Spitzer RF; Glazier RH; Pilon R; Arbess G; Simor A; Boyle E; Chitsike I; Chipato T; Gottesman M; Silverman M
Clin Infect Dis; 2007 Jan; 44(1):111-9. PubMed ID: 17143826
[TBL] [Abstract][Full Text] [Related]
11. Persistence of nevirapine exposure during the postpartum period after intrapartum single-dose nevirapine in addition to zidovudine prophylaxis for the prevention of mother-to-child transmission of HIV-1.
Cressey TR; Jourdain G; Lallemant MJ; Kunkeaw S; Jackson JB; Musoke P; Capparelli E; Mirochnick M
J Acquir Immune Defic Syndr; 2005 Mar; 38(3):283-8. PubMed ID: 15735445
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetic analysis of a nevirapine-based HIV-1 prevention of mother-to-child transmission program in Uganda to assess the impact of different dosing regimens for newborns.
Frank M; Harms G; Kunz A; Kloft C
J Clin Pharmacol; 2013 Mar; 53(3):294-304. PubMed ID: 23444284
[TBL] [Abstract][Full Text] [Related]
13. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
[TBL] [Abstract][Full Text] [Related]
14. Nevirapine Concentrations During the First Month of Life and Maternal Efavirenz Washout in High-Risk HIV-Exposed Infants Receiving Triple Antiretroviral Prophylaxis.
Anugulruengkitt S; Cressey TR; Suntarattiwong P; Ounchanum P; Srirompotong U; Jantarabenjakul W; Sophonphan J; Tawon Y; Punnahitanon S; Pancharoen C; Chokephaibulkit K; Puthanakit T;
Pediatr Infect Dis J; 2019 Feb; 38(2):152-156. PubMed ID: 30204660
[TBL] [Abstract][Full Text] [Related]
15. Impact of nevirapine (NVP) plasma concentration on selection of resistant virus in mothers who received single-dose NVP to prevent perinatal human immunodeficiency virus type 1 transmission and persistence of resistant virus in their infected children.
Chaix ML; Ekouevi DK; Peytavin G; Rouet F; Tonwe-Gold B; Viho I; Bequet L; Amani-Bosse C; Menan H; Leroy V; Rouzioux C; Dabis F
Antimicrob Agents Chemother; 2007 Mar; 51(3):896-901. PubMed ID: 17178792
[TBL] [Abstract][Full Text] [Related]
16. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
[TBL] [Abstract][Full Text] [Related]
17. Nevirapine concentrations in newborns receiving an extended prophylactic regimen.
Mirochnick M; Nielsen-Saines K; Pilotto JH; Pinto J; Jiménez E; Veloso VG; Parsons T; Watts DH; Moye J; Mofenson LM; Camarca M; Bryson Y;
J Acquir Immune Defic Syndr; 2008 Mar; 47(3):334-7. PubMed ID: 18398973
[TBL] [Abstract][Full Text] [Related]
18. Impact of human immunodeficiency virus type 1 (hiv-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent hiv-1 vertical transmission (hiv network for prevention trials 012 study).
Eshleman SH; Becker-Pergola G; Deseyve M; Guay LA; Mracna M; Fleming T; Cunningham S; Musoke P; Mmiro F; Jackson JB
J Infect Dis; 2001 Oct; 184(7):914-7. PubMed ID: 11509999
[TBL] [Abstract][Full Text] [Related]
19. Short Communication: Reduced Nevirapine Concentrations Among HIV-Positive Women Receiving Mefloquine for Intermittent Preventive Treatment for Malaria Control During Pregnancy.
Haaland RE; Otieno K; Martin A; Katana A; Dinh C; Slutsker L; Menendez C; Gonzalez R; Williamson J; Heneine W; Desai M
AIDS Res Hum Retroviruses; 2018 Nov; 34(11):912-915. PubMed ID: 30173559
[TBL] [Abstract][Full Text] [Related]
20. Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment.
Shapiro RL; Holland DT; Capparelli E; Lockman S; Thior I; Wester C; Stevens L; Peter T; Essex M; Connor JD; Mirochnick M
J Infect Dis; 2005 Sep; 192(5):720-7. PubMed ID: 16088821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
